Gene and Cell Therapy – News and Features

Genes have the ability to recognize similarities in each other from a distance, without any proteins or other biological molecules aiding the process, according to new research.

New ways to grow brain cells in the laboratory could eventually provide a way to treat Parkinson's disease, scientists say.

Using embryonic stem cells from mice, researchers have prompted the growth of healthy muscle cells in mice afflicted with a human model of Duchenne muscular dystrophy.

BioTime signs licensing agreement with WARF for 173 patents and patent applications relating to human embryonic stem cell technology created at the UW-Madison.

California Pacific Medical Center in San Francisco claims to have become the first medical research institution in the world to use a gene silencing therapy to treat Hepatitis B.

BrainStorm has expanded its collaboration with Rutgers University in an effort to cure spinal cord injuries through BrainStorm’s adult stem cell research.

The University Hospital has partnered with DomaniCell to provide a hospital-based cord blood banking program.

Research aimed at developing molecular bullets for ALS drug delivery.

The rights granted are exclusive for RNAi gene silencing using lentiviral vector technology for human gene therapy applications.

Children's Hospital Boston's stem cell researchers have converted skin cells from an adult into cells that look and act like embryonic stem cells.